This inventor holds 1 USPTO granted patent. Top assignee: Charité – Universitätsmedizin Berlin. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Elmehdi Belbaraka: Innovator in Gene Therapy
Introduction
Elmehdi Belbaraka is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of gene therapy, particularly in the development of specific T cell receptors. His work is vital in advancing medical treatments and therapies.
Latest Patents
Elmehdi holds a patent for "CD5 Specific T Cell Receptor Cell or Gene Therapy." This innovative approach has the potential to enhance the effectiveness of immunotherapies, providing new avenues for treating various diseases.
Career Highlights
Belbaraka is affiliated with Charité – Universitätsmedizin Berlin, one of Europe's largest university hospitals. His role at this prestigious institution allows him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
He has worked alongside notable colleagues such as Antonio Pezzutto and Thomas Blankenstein. Their combined expertise fosters an environment of innovation and discovery in the realm of gene therapy.
Conclusion
Elmehdi Belbaraka's contributions to gene therapy exemplify the impact of innovative thinking in medicine. His work continues to inspire advancements that may transform patient care in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile